Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 1071

Showing 1-25 of 1071 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1367-1401
Open Access | Times Cited: 755
Notch signaling pathway: architecture, disease, and therapeutics
Binghan Zhou, Wanling Lin, Yaling Long, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 628
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 460
Metastasis
Stefanie Gerstberger, Qingwen Jiang, Karuna Ganesh
Cell (2023) Vol. 186, Iss. 8, pp. 1564-1579
Open Access | Times Cited: 357
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Xiujie Sun, Bogang Wu, Huai-Chin Chiang, et al.
Nature (2021) Vol. 599, Iss. 7886, pp. 673-678
Open Access | Times Cited: 256
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4363-4363
Open Access | Times Cited: 240
Carbon dots: mysterious past, vibrant present, and expansive future
Boyang Wang, Geoffrey I. N. Waterhouse, Siyu Lu
Trends in Chemistry (2022) Vol. 5, Iss. 1, pp. 76-87
Closed Access | Times Cited: 163
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 161
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 146
Mechanisms driving the immunoregulatory function of cancer cells
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 140
Managing the TME to improve the efficacy of cancer therapy
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 134
Multimodal data fusion for cancer biomarker discovery with deep learning
Sandra Steyaert, Marija Pizurica, Divya Nagaraj, et al.
Nature Machine Intelligence (2023) Vol. 5, Iss. 4, pp. 351-362
Open Access | Times Cited: 134
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 134
Multifunctional nanoparticle-mediated combining therapy for human diseases
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 122
Early Tumor–Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
Ryul Kim, Minae An, Hyuk Lee, et al.
Cancer Discovery (2021) Vol. 12, Iss. 4, pp. 984-1001
Open Access | Times Cited: 121
Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation
Alexandra Mousset, Enora Lecorgne, Isabelle Bourget, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 757-775.e10
Open Access | Times Cited: 121
Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway
Shuhai Chen, Yuji Morine, Kazunori Tokuda, et al.
International Journal of Oncology (2021) Vol. 59, Iss. 2
Open Access | Times Cited: 111
Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression
Anirudh Sattiraju, Sang Jo Kang, Bruno Giotti, et al.
Immunity (2023) Vol. 56, Iss. 8, pp. 1825-1843.e6
Open Access | Times Cited: 110
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
Binghao Zhao, Huanzhang Li, Yu Xia, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 108
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Giulia Petroni, Aitziber Buqué, Lisa M. Coussens, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 6, pp. 440-462
Closed Access | Times Cited: 99
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
Lena Cords, Stefanie Engler, Martina Haberecker, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 396-412.e5
Open Access | Times Cited: 94
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
Loretah Chibaya, Jarin T. Snyder, Marcus Ruscetti
Seminars in Cancer Biology (2022) Vol. 86, pp. 827-845
Open Access | Times Cited: 84
Page 1 - Next Page

Scroll to top